ID   MDA-MB-231 ERbeta
AC   CVCL_IN18
SY   MDA Mb231 (ERb)
DR   cancercelllines; CVCL_IN18
DR   GEO; GSM246297
DR   GEO; GSM246298
DR   GEO; GSM246299
DR   GEO; GSM246300
DR   GEO; GSM246301
DR   GEO; GSM246302
DR   Wikidata; Q54904585
RX   PubMed=19321454;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 3468; ESR2.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 16
//
RX   PubMed=19321454; DOI=10.1074/jbc.M900365200;
RA   Nott S.L., Huang Y.-F., Li X.-D., Fluharty B.R., Qiu X., Welshons W.V.,
RA   Yeh S.-Y., Muyan M.;
RT   "Genomic responses from the estrogen-responsive element-dependent
RT   signaling pathway mediated by estrogen receptor alpha are required to
RT   elicit cellular alterations.";
RL   J. Biol. Chem. 284:15277-15288(2009).
//